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Introduction
Myeloid cells (macrophages and neutrophils) infiltrate and synthesize 
myeloperoxidase (MPO) at sites of inflammation, which might produce 
gentotoxicity at surrounding tissues. 
Previously, we found that “freezing” LPS-triggered macrophage activation with 
the nitrone spin trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO), prevented cell 
activation and death. Oxidation of proteins and genomic DNA was also blocked, 
with formation of protein- and DNA-DMPO nitrone adducts, as assessed by 
DMPO-based immuno-spin trapping with the polyclonal anti-DMPO serum. 
Interestingly, confocal microscopy analysis of these cells showed that MPO, 
genomic DNA, and DNA-DMPO nitrone adducts co-localized in the nuclear 
protuberances formed in LPS-activated macrophages. 
Based on these observations, and the fact that DNA is negatively charged 
and MPO is a cationic protein, we hypothesized that uptaken or newly 
synthesized MPO induces oxidative mutagenesis when activated at sites 
of inflammation.  We also tested whether resveratrol can prevent MPO-
driven DNA-centered radicals and further mutagenesis.
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Methods and Results
In order to understand MPO-induced formation of DNA-centered radicals, we studied 
DNA-DMPO nitrone adducts in calf thymus DNA treated with micromolar concentrations 
of hypochlorous acid (HOCl) added as a bolus or generated in situ by the MPO/H2O2/Cl−
system in the presence of DMPO. 
We also investigated DNA-DMPO nitrone adducts inside living cells containing MPO, 
such as in HL-60 cells exposed to glucose/glucose oxidase (GO) or in RAW264.7 cells 
activated with LPS and then exposed to a phorbol ester (PMA). 
In addition, we used A549 human airway epithelial cells pre-loaded with human 
MPO. When these cells were exposed to glucose/GO, the frequency of 6-
thioguanine-resistant cells—with the hypoxanthine-guanine phosphoribosyl 
transferase (hrpt) gene mutation, increased. 
 
The formation of DNA-centered radicals and HRPT mutation frequency in our cell 
systems  decreased by each of the following: the NADPH oxidase inhibitor apocynin; the 
MPO inhibitors salicylhydroxamic acid (SHA) and 4-aminobenzoic acid hydrazide 
(ABAH); the cell-permeable HOCl scavenger resveratrol; and DMPO, which traps DNA-
centered radicals and prevents further oxidation.  
Figure 1: Rationale for the study of MPO-driven gentoxic damage and interventions:
In the site of inflammation superoxide radical anion is produced by NADPH oxidase 2 
(NOX2) in inflammatory cells and then dismutated to H2O2. MPO uses H2O2  to oxidize 
chloride to HOCl (chlorination cycle of MPO). HOCl or chloramines formed in the medium 
can diffuse inside tissue cells, or be formed inside cells that take up MPO, to produce 
DNA-centered radicals. In red, possible sites of interventions and study of DNA-centered 
radicals are shown.  Insert shows the chemical structure of resveratrol. 
Possible sites of intervention to stop and study 
myeloperoxidase-driven damage to the genome at 
sites of inflammation
OH
OH
OHresveratrol
HOCl induces DNA-centered radicals
Figure 2: HOCl oxidizes DNA to form DNA-centered radicals as intermediates.  A) 
DMPO-based immuno-spin trapping analysis of DNA-centered radicals produced during 
the MPO-driven, HOCl-mediated  oxidation of DNA; B) ELISA analysis of DNA-centered 
radicals induced by HOCl using the anti-DMPO antibody.
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Kinetic study of DNA-centered radicals induced by 
HOCl using immuno-spin trapping
Figure 3: Kinetics of DNA-
centered radicals formation and 
trapping by DMPO. Open circles, 
5 µM calf-thymus DNA was 
incubated with 10 µM HOCl and 10 
mM DMPO was added a different 
times after addition of HOCl. Close 
circles: DNA was incubated with 
HOCl and 10 mM DMPO, and 1 
mM methionine was added at 
different times to scavenge HOCl 
and chloramines.
DNA-centered radicals induced by MPO 
chlorination activity is blocked by resveratrol
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Figure 4: MPO-driven, HOCl-induced DNA-DMPO nitrone adducts. A) Calf thymus DNA 
was incubated with MPO and H2O2  followed by addition of 50 mM DMPO. Reaction was 
performed in 10 mM sodium phosphate buffer, pH 7.4 with or without 100 mM Cl−.  B) same 
as A, but inhibitors of MPO and scavengers of HOCl were added at the concentrations 
indicated in the figure. Addition of reagents was performed before H2O2  addition. Nitrone 
adducts were determined by ELISA. Asterisks indicate P<0.05 with respect to no inhibitor or 
scavenger added.  
Resveratrol inhibits DNA-centered radicals
induced by the chlorination cycle of MPO
by scavenging HOCl
Figure 5: Resveratrol inhibits DNA oxidation by scavenging HOCl.  A) Resveratrol 
inhibits HOCl-induced DNA-DMPO nitrone adducts. B) Resveratrol inhibits HOCl-induced 
luminol chemiluminescence ( 5 µM luminol/5 µM HOCl, 2 mins reaction).
A B
Genomic DNA-centered radicals in HL-60 cells are 
produced by the chlorination cycle of MPO
A B C
Figure 6: MPO produces DNA-centered radicals in HL-60 cells. A) shows the 
schematic procedure to study DNA-centered radicals induced by incubation of HL-60 cells 
to H2O2. B) ELISA analysis in total genomic DNA isolated from HL-60 cells treated as in A. 
C) confocal microscopy analysis of HL-60 cells treated with H2O2  showing the unique 
nuclear localization of DNA-DMPO nitrone adducts. Inserts, show a single plane image of 
a typical cell.
Epithelial cells uptake MPO at sites of inflammation 
what makes them vulnerable to H2O2 in the site of 
inflammation: intervention with resveratrol
Figure 7: Uptake of MPO by epithelial cells can produce DNA-centered radicals at 
sites of inflammation. A) A549 human lung epithelial cells were loaded with 10 nM 
human MPO for 24 h and then taken up MPO was imaged using an antibody anti-MPO. B) 
as A but cells were incubated with 5.6 mM glucose/glucose oxidase (GO) and DMPO for 1 
h followed by measurement of viability (trypan blue exclusion) and DNA-nitrone adducts by 
ELISA in DNA extracted from the cells after treatment. C) same as B, but resveratrol was 
added 30 min before 5 mIU of GO. 
A549 cells loaded with 
M PO
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LPS-elicitation of  macrophages induces MPO  that  
makes them vulnerable to genomic damage upon 
activation
Figure 8. Resveratrol protects inflammatory cells against MPO-driven genotoxicity. A) 
RAW 264.7 cells were treated as shown in the scheme. B) upper panel, Western blot 
showing the induction of MPO expression in macrophages incubated with LPS according to 
scheme in A. Lower panel shows the ELISA analysis of DNA-DMPO nitrone adducts in the 
DNA extracted from LPS-treated macrophages incubated with the phorbol ester PMA as 
shown in A.  C) Shows the effect of HOCl scavengers, NOX2 inhibitors and MPO inhibitors 
on PMA-induced DNA-DMPO nitrone adducts in macrophages elicited with LPS.
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DMPO inhibits mutagenesis induced by HOCl by 
trapping DNA-centered radicals
Figure 9. DMPO inhibits MPO-driven, HOCl-triggered mutation in A549 human lung 
epithelial cells. A) A549 cells were loaded with MPO followed by incubation with 5.6 mM 
glucose/ 1 mIU/ml glucose oxidase (GO) and/or 25 mM DMPO as indicated in the figure. 
After 1 h incubation, the viability of the cells was determined using the MTT assay. B) Other 
T75 flasks were treated as in A and then rinsed with PBS and incubated in fresh medium 
(F12K with 5% FCS) for 7 days. After that, cells were incubated with fresh medium 
containing 5 µg/ml 6-thioguanine  (6-TG) for 14 days to select cells having the mutation in 
the hypoxanthine-guanine phosphoribosyl transferase (hrpt) gene. Mutant cells are 
resistant to 6-TG and proliferate forming colonies. Cell were trypsinized and counted in an 
hemocytometer. 
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Conclusions
Figure 10. The path from 
inflammation to carcinogenesis and 
interventions. Genomic DNA-centered 
radicals and further mutagenesis 
induced by activated myeloid cells at 
sites of inflammation, can be prevented 
by blocking MPO activity, scavenging 
HOCl, or trapping DNA-centered 
radicals. Our findings provide new 
therapeutic avenues for preventing 
carcinogenesis induced by infiltration 
and activation of myeloid cells at sites of 
inflammation, for example, in the lung 
exposed to particulate matter.  In red, 
possible sites of interventions to stop 
inflammation-induced carcinogenesis.
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